
FDA Commissioner Marty Makary has resigned following a tumultuous tenure marked by internal conflict, personnel turnover, and intense political pressure regarding the agency’s regulatory stance on vaping. The administration’s pivot toward a more industry-friendly approach, driven by a desire to secure support from young voters, culminated in the approval of previously stalled flavored vaping products from companies like Glass. This policy shift, which includes a new directive allowing companies to market nicotine products while awaiting formal pre-market approval, aims to replace unregulated black-market imports with a regulated domestic supply. However, public health experts warn that these changes risk undermining scientific standards and potentially fueling a resurgence in nicotine addiction among youth. The appointment of Kyle Diamantis as acting commissioner signals a commitment to prioritizing these administration-led policy goals over the previous, more cautious regulatory framework.
Sign in to continue reading, translating and more.
Continue